Healthcare provider profile · identity verified

Rohini Rau-Murthy, MD

Family Practice · BOSTON, MA · NPI 1346744349

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	372	108
Amlodipine Besylate	Amlodipine Besylate	254	74
Lisinopril	Lisinopril	194	52
Diclofenac Sodium	Diclofenac Sodium	164	48
Fluticasone Propionate	Fluticasone Propionate	156	46
Losartan Potassium	Losartan Potassium	136	39
Omeprazole	Omeprazole	114	35
Metoprolol Succinate	Metoprolol Succinate	101	32
Albuterol Sulfate Hfa	Albuterol Sulfate	89	24
Hydrochlorothiazide	Hydrochlorothiazide	86	19
Metformin Hcl	Metformin Hcl	82	27
Metformin Hcl Er	Metformin Hcl	76	21
Gabapentin	Gabapentin	75	17
Famotidine	Famotidine	72	24
Eliquis	Apixaban	70	15
Alendronate Sodium	Alendronate Sodium	67	16
Simvastatin	Simvastatin	67	17
Levothyroxine Sodium	Levothyroxine Sodium	55	15
Sertraline Hcl	Sertraline Hcl	55	12
Jardiance	Empagliflozin	54	16
Pravastatin Sodium	Pravastatin Sodium	52	17
Allopurinol	Allopurinol	51	17
Tamsulosin Hcl	Tamsulosin Hcl	49	17
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Carvedilol	Carvedilol	39	suppressed
Chlorthalidone	Chlorthalidone	38	12
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	37	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	37	12
Ibuprofen	Ibuprofen	35	15
Meloxicam	Meloxicam	35	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	32	11
Trazodone Hcl	Trazodone Hcl	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Atenolol	Atenolol	29	suppressed
Single Use Swab	Alcohol Antiseptic Pads	29	12
Trulicity	Dulaglutide	29	suppressed
Lidocaine	Lidocaine	28	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ketoconazole	Ketoconazole	27	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	13
Finasteride	Finasteride	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Valsartan	Valsartan	18	suppressed
Betamethasone Valerate	Betamethasone Valerate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Colchicine	Colchicine	17	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Proctosol-Hc	Hydrocortisone	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error